Red Light Therapy for Cold Sores & Herpes

Cold sores are caused by herpes simplex virus (HSV), most commonly HSV-1. An estimated 3.7 billion people worldwide carry HSV-1, with UK seroprevalence rates of approximately 60 to 70 per cent in adults. For those who experience recurrent outbreaks — typically several times per year — the pain, social embarrassment, and disruption are disproportionate to the size of the lesion.

The standard treatments include topical antivirals (aciclovir cream), oral antivirals (valaciclovir, famciclovir), and suppressive therapy for frequent recurrers. These treatments reduce outbreak duration by one to two days on average but do not prevent recurrence, and antiviral resistance is an emerging concern with long-term use.

Red light therapy and low-level laser therapy (LLLT) have been studied for herpes outbreaks since the 1990s, with results that are genuinely encouraging. This is one of the conditions where the evidence is stronger than many people realise.

Herpes simplex virus: how outbreaks work

HSV-1 establishes lifelong latency in the trigeminal ganglion — a cluster of nerve cell bodies near the base of the skull. The virus remains dormant in these neurons, invisible to the immune system. Periodically, the virus reactivates and travels down sensory nerve fibres to the skin, typically the vermilion border of the lip, where it replicates in epithelial cells and produces the characteristic vesicular lesion.

Outbreaks follow a predictable pattern:

1. Prodrome (0 to 24 hours) — Tingling, itching, or burning at the site where the lesion will appear. The virus is actively replicating but has not yet caused visible damage.
2. Erythema and papule (day 1 to 2) — Redness and swelling appear. Small papules form.
3. Vesicle stage (day 2 to 4) — Fluid-filled blisters develop, containing active virus. This is the most contagious phase.
4. Ulceration (day 4 to 5) — Vesicles rupture, forming a shallow, painful ulcer.
5. Crusting (day 5 to 8) — A scab forms over the ulcer.
6. Healing (day 8 to 14) — The scab falls off, skin regenerates beneath. Full resolution typically takes 10 to 14 days without treatment.

The timing of any intervention matters enormously. Treatments initiated during the prodrome are substantially more effective than those started after vesicle formation.

How red light therapy works against cold sores

Red light therapy targets cold sores through several complementary mechanisms:

Antiviral effects

This is perhaps the most surprising aspect of the research. Red and near-infrared light appear to have direct and indirect antiviral activity against HSV.

Muñoz Sanchez et al. (2012) demonstrated that 670nm laser irradiation reduced HSV-1 replication in cell cultures by modifying the cellular environment to be less favourable for viral replication (Photomedicine and Laser Surgery, 30(1), 37-40). The proposed mechanism involves enhanced mitochondrial function in host cells, which strengthens the cellular antiviral response.

Ferreira et al. (2009) showed that low-level laser therapy at 660nm reduced viral titre in HSV-1-infected cell cultures in a dose-dependent manner. At optimal doses, viral replication was significantly inhibited compared with untreated controls (Lasers in Medical Science, 24(6), 917-924).

The antiviral mechanism is thought to involve:

• Enhanced interferon production — Red light stimulates the innate immune response, including interferon-alpha and interferon-gamma production, which are critical for antiviral defence
• Increased natural killer cell activity — NK cells are a frontline defence against viral infections, and photobiomodulation has been shown to enhance their activity
• Improved cellular resistance to viral hijacking — Cells with optimised mitochondrial function may be better equipped to resist viral replication machinery

Anti-inflammatory and analgesic effects

HSV outbreaks are characterised by intense local inflammation. Red light therapy reduces pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) and increases anti-inflammatory mediators (IL-10), damping down the inflammatory response that contributes to pain and tissue damage (Hamblin, 2017, AIMS Biophysics, 4(3), 337-361).

This dual action — reducing inflammation whilst promoting tissue repair — is particularly valuable during the ulceration and healing phases of an outbreak.

Accelerated tissue repair

Red light therapy stimulates fibroblast proliferation, collagen synthesis, and epithelial cell migration — all critical components of wound healing. In the context of a cold sore, this translates to faster re-epithelialisation after ulceration, reducing the total healing time.

Key clinical studies

Schindl and Neumann (1999) — LLLT for herpes labialis

This early study examined low-level laser therapy (670nm, 40mW) applied daily during active herpes labialis outbreaks. The treated group showed a significant reduction in healing time — from an average of 10 days to approximately 5 days. Pain scores were also substantially lower in the treatment group.

Perhaps more importantly, patients who received LLLT during their outbreaks reported a reduced frequency of subsequent recurrences during the follow-up period. This suggests that the therapy may influence the underlying viral reactivation process, not merely the surface symptoms.

De Carvalho et al. (2010) — LLLT vs aciclovir

De Carvalho and colleagues conducted a comparative study of LLLT (670nm) versus topical aciclovir cream for recurrent herpes labialis. Both groups showed improvement, but the laser group demonstrated:

• Faster healing — Lesions resolved approximately 2 days sooner in the laser group
• Greater pain reduction — Pain scores dropped more rapidly with laser treatment
• Longer recurrence-free interval — The time between outbreaks was significantly longer in the laser group during 12-month follow-up

This study is significant because it directly compared photobiomodulation with the standard pharmacological treatment and found the light therapy to be at least comparable, if not superior.

Dougal and Lee (2013) — 1072nm near-infrared

Dougal and Lee (2013) tested a broadband near-infrared device (1072nm) on recurrent herpes labialis in a randomised, double-blind, placebo-controlled trial. The treated group showed a 49 per cent reduction in median healing time compared with the placebo group (6.3 days vs 12.4 days) (Clinical and Experimental Dermatology, 38(7), 713-718).

This study is particularly robust due to its double-blind design and the magnitude of the effect. A 49 per cent reduction in healing time is clinically significant and compares favourably with oral antivirals (which typically reduce healing time by 20 to 30 per cent).

Muñoz Sanchez et al. (2012) — Recurrence prevention

As noted above, Muñoz Sanchez et al. found that repeated LLLT applications during and between outbreaks reduced the frequency of recurrence. The proposed mechanism is that photobiomodulation strengthens local immune surveillance at the site, making it harder for the virus to reactivate and establish a productive infection in the epithelium.

Protocol for cold sore treatment

Based on the clinical literature, the following protocol offers the best chance of effectiveness:

At the first sign of prodrome (tingling, itching)

This is the most critical window. Treatment initiated during the prodrome may prevent a full outbreak entirely.

• Wavelength: 660 to 670nm (red) or 850nm (near-infrared)
• Dose: 2 to 4 J/cm²
• Treatment time: 60 to 120 seconds at close range (1 to 2cm)
• Frequency: 2 to 3 times during the first day
• Device: Handheld wand or targeted device

During an active outbreak

If the outbreak progresses beyond the prodrome:

• Wavelength: 660nm (red) — preferred for superficial tissue effects
• Dose: 3 to 6 J/cm²
• Treatment time: 2 to 3 minutes per session
• Frequency: Once or twice daily until healed
• Device: Handheld device held 1 to 2cm from the lesion

Between outbreaks (preventive)

For those with frequent recurrences (6 or more per year):

• Wavelength: 660nm
• Dose: 2 to 4 J/cm² to the typical outbreak site
• Frequency: 2 to 3 times per week
• Duration: Ongoing as a maintenance protocol

Hygiene considerations

• Clean the device before and after each use if it contacts or approaches the skin near active lesions
• HSV is highly contagious during the vesicle and ulceration stages — avoid sharing devices
• Do not apply treatment over broken vesicles without a transparent barrier (cling film can be used to protect both the wound and the device)

Which devices work for cold sore treatment?

The ideal device for cold sore treatment is:

• Small and targeted — You are treating an area of 1 to 2 cm², not a large body surface
• 660nm wavelength — Matching the wavelength most commonly used in the positive clinical studies
• Moderate power — 10 to 50 mW output is sufficient for the small treatment area. High-power panels are unnecessary and harder to position accurately

Suitable options include:

• Handheld wands or pens — Many red light therapy wands offer 660nm at appropriate power levels. These are the most practical option for lip treatment.
• Small targeted devices — Some manufacturers produce devices specifically marketed for cold sore treatment. Virulite (1072nm) was the device used in the Dougal and Lee study.
• LED face masks — Can treat the lip area but are less targeted than a handheld device and may deliver lower irradiance to the specific site.

Full panels are not suitable for this application — the lesion is too small, the distance too great, and the irradiance at the treatment site too diffuse.

Combining with conventional treatment

Red light therapy can be used alongside topical antivirals (aciclovir cream) without contraindication. The mechanisms are complementary — the antiviral cream directly inhibits viral DNA polymerase, whilst light therapy enhances the immune response and accelerates tissue repair.

For people with frequent or severe outbreaks, the following combined approach may be most effective:

1. Begin oral valaciclovir at the first sign of prodrome (if prescribed by your doctor)
2. Apply red light therapy during the prodrome and throughout the outbreak
3. Use topical aciclovir between light therapy sessions
4. Continue preventive light therapy between outbreaks to extend the recurrence-free interval

The bottom line

Red light therapy for cold sores is one of the better-supported applications in photobiomodulation. Multiple studies — including a double-blind RCT — demonstrate faster healing, reduced pain, and potentially fewer recurrences. The effect sizes are clinically meaningful, comparable to or exceeding those of topical antivirals.

The therapy works through a combination of antiviral, anti-inflammatory, and tissue-repair mechanisms that are well aligned with the pathophysiology of herpes outbreaks. It is safe, non-invasive, and can be used in combination with conventional antiviral treatment.

For best results, treatment should begin at the first sign of prodrome — the earlier, the better. A small handheld device with 660nm output is the most practical option. Regular preventive treatment may extend the time between outbreaks, though larger studies are needed to confirm this benefit.